Product NDC: | 63304-168 |
Proprietary Name: | Sertraline Hydrochloride |
Non Proprietary Name: | Sertraline Hydrochloride |
Active Ingredient(s): | 200 mg/1 & nbsp; Sertraline Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63304-168 |
Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077977 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070206 |
Package NDC: | 63304-168-10 |
Package Description: | 1000 TABLET, COATED in 1 BOTTLE (63304-168-10) |
NDC Code | 63304-168-10 |
Proprietary Name | Sertraline Hydrochloride |
Package Description | 1000 TABLET, COATED in 1 BOTTLE (63304-168-10) |
Product NDC | 63304-168 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sertraline Hydrochloride |
Dosage Form Name | TABLET, COATED |
Route Name | ORAL |
Start Marketing Date | 20070206 |
Marketing Category Name | ANDA |
Labeler Name | Ranbaxy Pharmaceuticals Inc. |
Substance Name | SERTRALINE HYDROCHLORIDE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |